Switch to:

Arrowhead Pharmaceuticals YoY EBITDA Growth

: -545.28% (As of Sep. 2020)
View and export this data going back to 1997. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Arrowhead Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2020 was -545.28%.

Arrowhead Pharmaceuticals's EBITDA per Share for the three months ended in Sep. 2020 was $-0.47.


Arrowhead Pharmaceuticals YoY EBITDA Growth Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arrowhead Pharmaceuticals Annual Data
Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.33 65.10 -40.27 208.65 -230.03

Arrowhead Pharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 193.81 -129.13 -186.86 -171.21 -545.28

Arrowhead Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Arrowhead Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Sep. 2020 is calculated as:

YoY EBITDA Growth (A: Sep. 2020 )
=(EBITDA per Share (A: Sep. 2020 )-EBITDA per Share (A: Sep. 2019 ))/ | EBITDA per Share (A: Sep. 2019 ) |
=(-0.866-0.666)/ | 0.666 |
=-230.03 %

Arrowhead Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Sep. 2020 is calculated as:

YoY EBITDA Growth (Q: Sep. 2020 )
=(EBITDA per Share (Q: Sep. 2020 )-EBITDA per Share (Q: Sep. 2019 )) / | EBITDA per Share (Q: Sep. 2019 )) |
=(-0.472-0.106)/ | 0.106 |
=-545.28 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arrowhead Pharmaceuticals YoY EBITDA Growth Related Terms


Arrowhead Pharmaceuticals YoY EBITDA Growth Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)